72 related articles for article (PubMed ID: 10757070)
1. Loss of heterozygosity in papillary and follicular thyroid carcinoma: a mini review.
Gillespie JW; Nasir A; Kaiser HE
In Vivo; 2000; 14(1):139-40. PubMed ID: 10757070
[TBL] [Abstract][Full Text] [Related]
2. Differential loss of heterozygosity at 7q31.2 in follicular and papillary thyroid tumors.
Zhang JS; Nelson M; McIver B; Hay ID; Goellner JR; Grant CS; Eberhardt NL; Smith DI
Oncogene; 1998 Aug; 17(6):789-93. PubMed ID: 9715281
[TBL] [Abstract][Full Text] [Related]
3. Molecular evidence for the same clonal origin of multifocal papillary thyroid carcinomas.
McCarthy RP; Wang M; Jones TD; Strate RW; Cheng L
Clin Cancer Res; 2006 Apr; 12(8):2414-8. PubMed ID: 16638846
[TBL] [Abstract][Full Text] [Related]
4. Loss of heterozygosity on chromosome 16p and 18q in anaplastic thyroid carcinoma.
Kadota M; Tamaki Y; Sekimoto M; Fujiwara Y; Aritake N; Hasegawa S; Kobayashi T; Ikeda T; Horii A; Monden M
Oncol Rep; 2003; 10(1):35-8. PubMed ID: 12469141
[TBL] [Abstract][Full Text] [Related]
5. Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas.
Jones TD; Eble JN; Wang M; MacLennan GT; Delahunt B; Brunelli M; Martignoni G; Lopez-Beltran A; Bonsib SM; Ulbright TM; Zhang S; Nigro K; Cheng L
Clin Cancer Res; 2005 Oct; 11(20):7226-33. PubMed ID: 16243792
[TBL] [Abstract][Full Text] [Related]
6. Loss of heterozygosity in 73 human thyroid tumors.
Wozniak A; Wiench M; Olejniczak A; Wloch J; Lachinski A; Lange D; Olczyk T; Jarzab B; Limon J
Neuro Endocrinol Lett; 2005 Oct; 26(5):521-5. PubMed ID: 16264407
[TBL] [Abstract][Full Text] [Related]
7. [Detailed mapping and clinical significance of loss of heterozygosity on 9p13-23 in laryngeal squamous cell carcinoma by microsatellite analysis].
Xu XF; Tang PZ; Cheng SJ
Ai Zheng; 2003 May; 22(5):452-7. PubMed ID: 12753701
[TBL] [Abstract][Full Text] [Related]
8. High frequency of loss of heterozygosity in imprinted, compared with nonimprinted, genomic regions in follicular thyroid carcinomas and atypical adenomas.
Sarquis MS; Weber F; Shen L; Broelsch CE; Jhiang SM; Zedenius J; Frilling A; Eng C
J Clin Endocrinol Metab; 2006 Jan; 91(1):262-9. PubMed ID: 16249278
[TBL] [Abstract][Full Text] [Related]
9. [Loss of heterozygosity on chromosome 3p in thyroid tumors].
Hu MJ; Xu HD; Zhou R; Li XF; Zhang HY
Zhonghua Bing Li Xue Za Zhi; 2008 May; 37(5):305-8. PubMed ID: 18956647
[TBL] [Abstract][Full Text] [Related]
10. Studies of allelic loss in thyroid tumors reveal major differences in chromosomal instability between papillary and follicular carcinomas.
Ward LS; Brenta G; Medvedovic M; Fagin JA
J Clin Endocrinol Metab; 1998 Feb; 83(2):525-30. PubMed ID: 9467569
[TBL] [Abstract][Full Text] [Related]
11. A novel chromosomal translocation t(3;5)(q12;p15.3) and loss of heterozygosity on chromosome 22 in a multifocal follicular variant of papillary thyroid carcinoma presenting with skin metastases.
Smit JW; Van Zelderen-Bhola S; Merx R; De Leeuw W; Wessels H; Vink R; Morreau H
Clin Endocrinol (Oxf); 2001 Oct; 55(4):543-8. PubMed ID: 11678839
[TBL] [Abstract][Full Text] [Related]
12. Clonal origin of lymph node metastases in bladder carcinoma.
Jones TD; Carr MD; Eble JN; Wang M; Lopez-Beltran A; Cheng L
Cancer; 2005 Nov; 104(9):1901-10. PubMed ID: 16196038
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of a region on chromosome 1p in ovarian serous carcinoma that is frequently deleted in uterine papillary serous carcinoma.
Herzog TJ; Kowalski LD; Liu H; Arlt M; Swisher E
Gynecol Oncol; 2001 Jul; 82(1):139-42. PubMed ID: 11426975
[TBL] [Abstract][Full Text] [Related]
14. Altered expression and loss of heterozygosity of the LOT1 gene in ovarian cancer.
Cvetkovic D; Pisarcik D; Lee C; Hamilton TC; Abdollahi A
Gynecol Oncol; 2004 Dec; 95(3):449-55. PubMed ID: 15581945
[TBL] [Abstract][Full Text] [Related]
15. ras mutations in follicular variant of papillary thyroid carcinoma.
De Micco C
Am J Clin Pathol; 2003 Nov; 120(5):803; author reply 804. PubMed ID: 14608909
[No Abstract] [Full Text] [Related]
16. Molecular evidence supporting field effect in urothelial carcinogenesis.
Jones TD; Wang M; Eble JN; MacLennan GT; Lopez-Beltran A; Zhang S; Cocco A; Cheng L
Clin Cancer Res; 2005 Sep; 11(18):6512-9. PubMed ID: 16166427
[TBL] [Abstract][Full Text] [Related]
17. Genetic mutations in thyroid carcinoma.
Taccaliti A; Boscaro M
Minerva Endocrinol; 2009 Mar; 34(1):11-28. PubMed ID: 19209125
[TBL] [Abstract][Full Text] [Related]
18. Clonal divergence and genetic heterogeneity in clear cell renal cell carcinomas with sarcomatoid transformation.
Jones TD; Eble JN; Wang M; Maclennan GT; Jain S; Cheng L
Cancer; 2005 Sep; 104(6):1195-203. PubMed ID: 16047350
[TBL] [Abstract][Full Text] [Related]
19. Loss of heterozygosity in primary lung cancer using laser capture microdissection and WAVE DNA fragment analysis techniques.
Zhu W; Zou H; Beck A; Chervinsky D; Malik D; Brooks J; Tan D
Med Sci Monit; 2002 Mar; 8(3):BR95-9. PubMed ID: 11889456
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic and prognostic value of angiogenesis-modulating genes in malignant thyroid neoplasms.
Kebebew E; Peng M; Reiff E; Duh QY; Clark OH; McMillan A
Surgery; 2005 Dec; 138(6):1102-9; discussion 1109-10. PubMed ID: 16360397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]